These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31924201)

  • 21. Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).
    Couñago F; Montemuiño S; Martin M; Taboada B; Calvo-Crespo P; Samper-Ots MP; Alcántara P; Corona J; López-Guerra JL; Murcia-Mejía M; López-Mata M; Jové-Teixidó J; Chust M; Díaz-Díaz V; de Ingunza-Barón L; García-Cañibano T; Couselo ML; Del Cerro E; Moradiellos J; Amor S; Varela A; Puertas MM; Thuissard IJ; Sanz-Rosa D; de Dios NR
    Clin Transl Oncol; 2019 Jun; 21(6):735-744. PubMed ID: 30430394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small-cell lung cancer.
    Lopez Guerra JL; Gomez DR; Zhuang Y; Levy LB; Eapen G; Liu H; Mohan R; Komaki R; Cox JD; Liao Z
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e537-43. PubMed ID: 22420964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease.
    Ferguson MK; Vigneswaran WT
    Ann Thorac Surg; 2008 Apr; 85(4):1158-64; discussion 1164-5. PubMed ID: 18355489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal pulmonary function tests predict the development of radiation-induced pneumonitis in advanced non-small cell lung Cancer.
    Torre-Bouscoulet L; Muñoz-Montaño WR; Martínez-Briseño D; Lozano-Ruiz FJ; Fernández-Plata R; Beck-Magaña JA; García-Sancho C; Guzmán-Barragán A; Vergara E; Blake-Cerda M; Gochicoa-Rangel L; Maldonado F; Arroyo-Hernández M; Arrieta O
    Respir Res; 2018 Apr; 19(1):72. PubMed ID: 29690880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrence dynamics after trimodality therapy (Neoadjuvant concurrent chemoradiotherapy and surgery) in patients with stage IIIA (N2) lung cancer.
    Lee J; Kim HK; Park BJ; Cho JH; Choi YS; Zo JI; Shim YM; Pyo H; Ahn YC; Ahn JS; Ahn MJ; Park K; Kim J
    Lung Cancer; 2018 Jan; 115():89-96. PubMed ID: 29290268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancer.
    Rivera MP; Detterbeck FC; Socinski MA; Moore DT; Edelman MJ; Jahan TM; Ansari RH; Luketich JD; Peng G; Monberg M; Obasaju CK; Gralla RJ
    Chest; 2009 Jun; 135(6):1588-1595. PubMed ID: 19188545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoadjuvant chemoradiation and surgery improves survival outcomes compared with definitive chemoradiation in the treatment of stage IIIA N2 non-small-cell lung cancer.
    Darling GE; Li F; Patsios D; Massey C; Wallis AG; Coate L; Keshavjee S; Pierre A; De Perrot M; Yasufuku K; Cypel M; Waddell T
    Eur J Cardiothorac Surg; 2015 Nov; 48(5):684-90; discussion 690. PubMed ID: 25567960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
    Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP
    Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial.
    Pless M; Stupp R; Ris HB; Stahel RA; Weder W; Thierstein S; Gerard MA; Xyrafas A; Früh M; Cathomas R; Zippelius A; Roth A; Bijelovic M; Ochsenbein A; Meier UR; Mamot C; Rauch D; Gautschi O; Betticher DC; Mirimanoff RO; Peters S;
    Lancet; 2015 Sep; 386(9998):1049-56. PubMed ID: 26275735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer.
    Gopal R; Starkschall G; Tucker SL; Cox JD; Liao Z; Hanus M; Kelly JF; Stevens CW; Komaki R
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):114-20. PubMed ID: 12694829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of different treatment modalities on survival in elderly patients with locally advanced non-small cell lung cancer.
    Sakin A; Sahin S; Atci MM; Sakin A; Yasar N; Geredeli C; Aksaray F; Cihan S
    Pulmonology; 2021; 27(1):26-34. PubMed ID: 31839507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant treatment followed by surgery versus definitive chemoradiation in stage IIIA-N2 non-small-cell lung cancer: A multi-institutional study by the oncologic group for the study of lung cancer (Spanish Radiation Oncology Society).
    Couñago F; Rodriguez de Dios N; Montemuiño S; Jové-Teixidó J; Martin M; Calvo-Crespo P; López-Mata M; Samper-Ots MP; López-Guerra JL; García-Cañibano T; Díaz-Díaz V; de Ingunza-Barón L; Murcia-Mejía M; Alcántara P; Corona J; Puertas MM; Chust M; Couselo ML; Del Cerro E; Moradiellos J; Amor S; Varela A; Thuissard IJ; Sanz-Rosa D; Taboada B
    Lung Cancer; 2018 Apr; 118():119-127. PubMed ID: 29571989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical benefit of neoadjuvant chemoradiotherapy for the avoidance of pneumonectomy; assessment in 12 consecutive centrally located non-small cell lung cancers.
    Misumi K; Harada H; Tsubokawa N; Tsutani Y; Matsumoto K; Miyata Y; Yamashita Y; Okada M
    Gen Thorac Cardiovasc Surg; 2017 Jul; 65(7):392-399. PubMed ID: 28432576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary rehabilitation during induction chemoradiotherapy for lung cancer improves pulmonary function.
    Tarumi S; Yokomise H; Gotoh M; Kasai Y; Matsuura N; Chang SS; Go T
    J Thorac Cardiovasc Surg; 2015 Feb; 149(2):569-73. PubMed ID: 25451483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is There a Survival Benefit in Patients With Stage IIIA (N2) Non-small Cell Lung Cancer Receiving Neoadjuvant Chemotherapy and/or Radiotherapy Prior to Surgical Resection: A Systematic Review and Meta-analysis.
    Xu YP; Li B; Xu XL; Mao WM
    Medicine (Baltimore); 2015 Jun; 94(23):e879. PubMed ID: 26061306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Single-breath and rebreathing methods for measurement of pulmonary diffusing function: a comparative study].
    Liu QX; Zheng JP; Xie YQ; Guan WJ; Jiang CY; An JY; Yu XX; Liu WT; Gao Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jul; 36(7):510-5. PubMed ID: 24262087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small-cell lung cancer.
    Lopez Guerra JL; Gomez D; Zhuang Y; Levy LB; Eapen G; Liu H; Mohan R; Komaki R; Cox JD; Liao Z
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1573-9. PubMed ID: 22768989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of neoadjuvant chemo(radio)therapy and resection for stage IIIA non-small cell lung cancer in The Netherlands.
    Joosten PJM; Damhuis RAM; van Diessen JNA; de Langen JA; Belderbos JSA; Smit EF; Klomp HM; Veenhof AAFA; Hartemink KJ
    Acta Oncol; 2020 Jul; 59(7):748-752. PubMed ID: 32347142
    [No Abstract]   [Full Text] [Related]  

  • 39. Is trimodality approach better then bimodality in stage IIIA, N2 positive non-small cell lung cancer?
    Park BB; Park JO; Kim H; Ahn YC; Choi YS; Kim K; Kim J; Shim YM; Ahn JS; Park K
    Lung Cancer; 2006 Sep; 53(3):323-30. PubMed ID: 16844258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus neoadjuvant chemotherapy plus concurrent chemoradiotherapy for ascending or descending types of nasopharyngeal carcinoma: A retrospective study.
    Lin Q; Lu L; Wang X; Lin Y; Chen Y; Chen H; Chen S; Lin S; Zhang Y; Zheng P; Chen X
    Am J Otolaryngol; 2022; 43(1):103193. PubMed ID: 34509080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.